| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 09/11/2001 | CA2125175C New peptide derivatives |
| 09/11/2001 | CA2021528C Muteins of human erythropoietin, the preparation thereof and the use thereof |
| 09/07/2001 | WO2001064911A2 18232, a dual specificity phosphatase |
| 09/07/2001 | WO2001064907A2 Lipid metabolism enzymes |
| 09/07/2001 | WO2001064886A2 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| 09/07/2001 | WO2001064885A1 Chordin-like-2 molecules and uses thereof |
| 09/07/2001 | WO2001064884A2 G12l, a gene associated with the thermal response |
| 09/07/2001 | WO2001064879A2 G-proteins coupled receptor related polypeptides |
| 09/07/2001 | WO2001064870A2 Mutated cyclin g1 protein |
| 09/07/2001 | WO2001064862A1 Human monoclonal antibodies against oxidized ldl receptor and medicinal use thereof |
| 09/07/2001 | WO2001064743A1 GPib-LIPID BOND CONSTRUCT AND USE THEREOF |
| 09/07/2001 | WO2001064692A1 Cardioprotective phosphonates and malonates |
| 09/07/2001 | WO2001064691A1 Il-8 receptor antagonists |
| 09/07/2001 | WO2001064679A1 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases |
| 09/07/2001 | WO2001064677A1 Novel imidazotriazinones and the use thereof |
| 09/07/2001 | WO2001064669A1 Pyrazole ether derivatives as anti-inflammatory/analgesic agents |
| 09/07/2001 | WO2001064652A1 Substituted 5-methyldihydropyridazinones and their use in the prophylaxis and/or treatment of anemias |
| 09/07/2001 | WO2001064643A2 BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa |
| 09/07/2001 | WO2001064642A2 Benzamides and related inhibitors of factor xa |
| 09/07/2001 | WO2001064632A1 Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same |
| 09/07/2001 | WO2001064236A2 METHODS FOR TREATING FSH RELATED CONDITIONS WITH GnRH ANTAGONISTS |
| 09/07/2001 | WO2001064234A1 Casein derived peptides and uses thereof in therapy |
| 09/07/2001 | WO2001064219A2 Use of cytoskeleton modifying compounds against intracranial pressure changes |
| 09/07/2001 | WO2001064208A1 Il-8 receptor antagonists |
| 09/07/2001 | WO2001064165A2 Il-8 receptor antagonists |
| 09/07/2001 | WO2001019823A3 Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity |
| 09/07/2001 | WO2001019780A3 Novel derivatives of dicarboxylic acid having pharmaceutical properties |
| 09/07/2001 | WO2001010841A3 Fluorene derivatives as integrin inhibitors |
| 09/07/2001 | WO2001010383A3 Caspase inhibitors and uses thereof |
| 09/07/2001 | WO2000075107A3 Bradykinin receptor antagonists |
| 09/07/2001 | WO2000002912A3 Disintegrin homologs |
| 09/07/2001 | CA2401993A1 Human monoclonal antibodies against oxidized ldl receptor and pharmaceutical uses thereof |
| 09/07/2001 | CA2401834A1 Novel imidazotriazinones and the use thereof |
| 09/07/2001 | CA2401697A1 Pyrazole ether derivatives as anti-inflammatory/analgesic agents |
| 09/07/2001 | CA2401660A1 Lipid metabolism enzymes |
| 09/07/2001 | CA2401659A1 Il-8 receptor antagonists |
| 09/07/2001 | CA2401550A1 Casein derived peptides and uses thereof in therapy |
| 09/07/2001 | CA2401453A1 G-proteins coupled receptor related polypeptides |
| 09/07/2001 | CA2401175A1 Chordin-like-2 molecules and uses thereof |
| 09/07/2001 | CA2401173A1 G12l, a gene associated with the thermal response |
| 09/07/2001 | CA2401022A1 Methods for treating fsh related conditions with gnrh antagonists |
| 09/07/2001 | CA2400116A1 Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same |
| 09/06/2001 | US20010020033 Selective factor xa inhibitors |
| 09/06/2001 | US20010020021 Metalloprotease inhibitor |
| 09/06/2001 | US20010020013 Polymerase inhibitors |
| 09/06/2001 | US20010020003 Polypeptides |
| 09/06/2001 | DE10010430A1 Medicaments, especially for treating anemia, containing 6-(4-(acylamino)-phenyl)-5-ethyl-dihydropyridazinones having erythropoietin sensitizing and erythropoiesis stimulating activity |
| 09/06/2001 | DE10010429A1 New 6-(4-sulfonamido-phenyl)-5-methyl-dihydropyridazinones, having erythropoietin sensitizing and erythropoiesis stimulating activity, useful for treating anemia |
| 09/06/2001 | DE10010426A1 Medicaments, especially for treating anemia, containing 6-(4-(acylamino)-phenyl)-dihydropyridazinones having erythropoietin sensitizing and erythropoiesis stimulating activity |
| 09/06/2001 | DE10010425A1 Medicaments for treating anemia, containing new or known 6-(4-(acylamino)-phenyl)-5-methyl-dihydropyridazinones having erythropoietin sensitizing and erythropoiesis stimulating activity |
| 09/06/2001 | DE10010423A1 New 6-(4-acylamino-phenyl)-2,5-methyl-dihydropyridazinones, having erythropoietin sensitizing and erythropoiesis stimulating activity, useful for treating anemia |
| 09/06/2001 | DE10010422A1 New 6-(4-carboxy-phenyl)-dihydropyridazinone esters or amides, having erythropoietin sensitizing and erythropoiesis stimulating activity, useful for treating anemia |
| 09/06/2001 | DE10010067A1 New 2-phenyl-imidazo (5,1-f) (1,2,4) triazin-4-one derivatives, are phosphodiesterase inhibitors useful for treating cardiovascular, cerebrovascular or urogenital disorders |
| 09/05/2001 | EP1130087A2 A method to identify compounds that alter the apoptotic process |
| 09/05/2001 | EP1129720A2 Stabilized granulocyte colony stimulating factor |
| 09/05/2001 | EP1129718A2 Therapeutic uses of bactericidal/permeability increasing protein products |
| 09/05/2001 | EP1129189A2 Human cell surface receptor proteins |
| 09/05/2001 | EP1129175A2 Promotion of self-renewal and improved gene transduction of hematopoietic stem cells by histone deacetylase inhibitors |
| 09/05/2001 | EP1129089A1 Spiro-indolines as y5 receptor antagonists |
| 09/05/2001 | EP1129086A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 09/05/2001 | EP1129078A2 Indazole derivatives with 5-ht2 receptor activity |
| 09/05/2001 | EP1128842A1 Method of treating heparin-induced thrombocytopenia |
| 09/05/2001 | EP1128841A2 Pharmaceutical preparation containing a receptor-antagonist for treating blood-clotting disorders |
| 09/05/2001 | EP1128813A1 An inhalation system |
| 09/05/2001 | EP1059889A4 Treatment of brain edema using carbonic anhydrase enzyme inhibitor |
| 09/05/2001 | EP0746334B1 Pharmaceutical preparation containing plasminogen activators |
| 09/05/2001 | EP0574510B1 2,4-diaryl-1,3-dithiolanes as platelet activating factor receptor antagonists and 5-lipoxygenase inhibitors |
| 09/05/2001 | CN1311691A Antithrombotic agent and humanized anti-von willebrand factor monoclonal antibody |
| 09/05/2001 | CN1311209A New polypeptide-human ataxia-telangiectatic mutation protein 9 and polynucleotide for coding said polypeptide |
| 09/05/2001 | CN1311023A Medicine for anti-thrombus and cleaning blood and preparing method |
| 09/05/2001 | CN1070377C Notoginseng medicinal oral liquid |
| 09/04/2001 | US6284871 A peptide of 8-20 amino acids involved in binding to activated factor ix; drug therpy for thrombotic disorders |
| 09/04/2001 | US6284756 Anticoagulant |
| 09/04/2001 | US6284268 Cyclosporin, synergistic |
| 09/04/2001 | CA2037410C Therapeutic compositions with controlled release of medicaments supported on crosslinked polymers and coated with polymer films, and their preparation process |
| 08/30/2001 | WO2001062905A2 Integrin antagonists |
| 08/30/2001 | WO2001062901A2 Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof |
| 08/30/2001 | WO2001062789A1 Human polynucleotides, polypeptides, and antibodies |
| 08/30/2001 | WO2001062775A2 Novel antiarrhythmic peptides |
| 08/30/2001 | WO2001062763A1 Method for inhibiting trypsin-type serine proteases |
| 08/30/2001 | WO2001062758A1 Pteridine compounds for the treatment of psoriasis |
| 08/30/2001 | WO2001062757A1 Novel compounds |
| 08/30/2001 | WO2001062735A1 Novel malonic acid derivatives, processes for their preparation, their use as inhibitor of factor xa activity and pharmaceutical compositions containing them |
| 08/30/2001 | WO2001062733A1 Ortho-sulfonamido aryl hydroxamic acids, process for their preparation and their use as matrix metalloproteinase inhibitors |
| 08/30/2001 | WO2001062729A1 Novel compounds |
| 08/30/2001 | WO2001062728A1 Novel compounds |
| 08/30/2001 | WO2001062717A1 Aminosulfonylbiphenyl derivatives |
| 08/30/2001 | WO2001062312A1 Foam-forming wound dressing |
| 08/30/2001 | WO2001062278A1 Hemostatic soluble cellulose fibers containing coagulating protein for treating wound and process for producing the same |
| 08/30/2001 | WO2001062245A2 Bilirubin or biliverdin degradation fragments |
| 08/30/2001 | WO2001012195A3 Use of morphine derivatives as medicaments for the treatment of neuropathic problems |
| 08/30/2001 | WO2000074701A3 Method and composition for inhibiting cardiovascular cell proliferation |
| 08/30/2001 | WO2000071510A3 INHIBITORS OF FACTOR Xa |
| 08/30/2001 | WO2000040733A9 Human cyclic nucleotide pdes |
| 08/30/2001 | US20010018598 Compositions, systems, and methods for creating in situ, chemically cross-linked, mechanical barriers |
| 08/30/2001 | US20010018449 Hypotensive agent, endothelial damage, arteriosclerosis, antidiabetic agents |
| 08/30/2001 | US20010018447 Il-8 receptor antagonists |
| 08/30/2001 | US20010018428 C-pyrazole A2A receptor agonists |
| 08/30/2001 | US20010018414 Modified vitamin K-dependent polypeptides |
| 08/30/2001 | US20010018052 Use of anti-coagulation factor antibodies as long-lasting protective agents |